Welcome to DU!
The truly grassroots left-of-center political community where regular people, not algorithms, drive the discussions and set the standards.
Join the community:
Create a free account
Support DU (and get rid of ads!):
Become a Star Member
Latest Breaking News
General Discussion
The DU Lounge
All Forums
Issue Forums
Culture Forums
Alliance Forums
Region Forums
Support Forums
Help & Search
General Discussion
Related: Editorials & Other Articles, Issue Forums, Alliance Forums, Region ForumsIs Israel or the UK right when it comes to COVID-19 vaccine effectiveness?
https://www.jpost.com/%20israel-pfizer-news/is-israel-or-the-uk-right-when-it-comes-to-covid-19-vaccine-effectiveness-674766Is Israel or the UK right when it comes to COVID-19 vaccine effectiveness?
According to one Israeli researcher, both sets of data could be correct. Here is why:
By MAAYAN JAFFE-HOFFMAN JULY 24, 2021 18:21
Is the Pfizer coronavirus vaccine 88% or only 39% effective against preventing symptomatic infection?
Two separate studies, one published by the Israeli Health Ministry and the other published in the New England Journal of Medicine late Thursday showed striking differences.
This discrepancy is kind of unsettling and needs to be further investigated, said Prof. Cyrille Cohen, a member of the advisory committee for clinical trials on SARS-COV2 vaccines at the Health Ministry.
Specifically, the ministry's study found that the Pfizer coronavirus vaccine was only 40% effective against symptomatic cases of COVID-19 and 39% effective at stopping infection at all against the Delta variant.
...
InfoView thread info, including edit history
TrashPut this thread in your Trash Can (My DU » Trash Can)
BookmarkAdd this thread to your Bookmarks (My DU » Bookmarks)
9 replies, 664 views
ShareGet links to this post and/or share on social media
AlertAlert this post for a rule violation
PowersThere are no powers you can use on this post
EditCannot edit other people's posts
ReplyReply to this post
EditCannot edit other people's posts
Rec (1)
ReplyReply to this post
9 replies
= new reply since forum marked as read
Highlight:
NoneDon't highlight anything
5 newestHighlight 5 most recent replies
Is Israel or the UK right when it comes to COVID-19 vaccine effectiveness? (Original Post)
dalton99a
Jul 2021
OP
It seems what we see here, vacs are preventing more than they are not preventing.
LizBeth
Jul 2021
#1
LizBeth
(9,952 posts)1. It seems what we see here, vacs are preventing more than they are not preventing.
kentuck
(111,056 posts)2. Weren't the Israeli numbers a much lower sampling?
Seems I read that somewhere?
uponit7771
(90,304 posts)3. I read the New England study it doesn't define the efficacy of the vaccines it just says effective a
... it doesn't say infection or hospitalization / death
LisaL
(44,972 posts)4. We (US) are more similar to Israel than to UK.
We were giving Pfizer to all age groups, from young to old.
Phoenix61
(16,994 posts)9. We are more similar to the UK for the
timeline of when vaccines were given.
Shermann
(7,399 posts)5. The Israel dataset seems to be more representative
It includes more time for the vaccination protection to wane and also includes the over 40 group.
Ms. Toad
(34,001 posts)8. Hard to tell, since they are not releasing the data.
That is what raises the most questions for me about the Israeli report.
Tomconroy
(7,611 posts)6. The Pfizer vaccine has been shown to be highly effective
Last edited Sat Jul 24, 2021, 01:42 PM - Edit history (1)
Against the Delta variant in a number of studies
https://www.healthline.com/health-news/heres-how-well-covid-19-vaccines-work-against-the-delta-variant#Vaccines-vs.-delta-variant
Ms. Toad
(34,001 posts)7. Interesting -
When England launched its vaccination campaign, it did not have enough doses to vaccinate the population according to Pfizers recommended regime of two doses three weeks apart. As such, it spread doses out to between four and 12 weeks to allow more people to get at least one jab. Specifically, the new research showed that neutralizing antibody levels, the level of those antibodies responsible for defending cells from pathogens, were higher after the extended dosing interval (six to 14 weeks) compared to the conventional three-to-four-week regime.